The Ph.D. program at Gallaudet University prepares scholars and practitioners to lead in the design, development, and ...
Johnson & Johnson (NYSE:JNJ), the worldwide leader in multiple myeloma, today announced new data from the investigational Phase 3 MajesTEC-3 study that demonstrate the potential of TECVAYLI® ...
Akamai Technologies, Inc. (AKAM) 53rd Annual Nasdaq Investor Conference December 9, 2025 6:30 AM ESTCompany ParticipantsF.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback